Discover Tenders by Motion Capture Advance Medical Procedures Sector

Find the most relevant tenders for Motion Capture Advance Medical Procedures. Access the latest tender notices from various government and private organizations published across hundreds of websites and newspapers.Obtain complete and accurate information on Motion Capture Advance Medical Procedures tenders, including all tender documents, RFPs, RFQs,and more. Utilize our advanced filters to search for Motion Capture Advance Medical Procedures tenders by organization, tender value, opening and closing dates, and more.

Filter Your Search

Country

Sector

Region

Funding Agency

Biomedical Advanced Research And Development Authority Barda Broad Agency Announcement Baa

Deadline: 25 Sep 2028

United States

Ref. No.: 4718977

EMD:Ref Document

Bid Value: Ref Document

1062 Days Left

Tactical Broad Agency Announcement Baa

Deadline: 22 Nov 2028

United States

Ref. No.: 4718520

EMD:Ref Document

Bid Value: Ref Document

1120 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 4717233

EMD:Ref Document

Bid Value: Ref Document

428 Days Left

Tactical Broad Agency Announcement Baa

Deadline: 22 Nov 2028

United States

Ref. No.: 4697594

EMD:Ref Document

Bid Value: Ref Document

1120 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicines With The Active Ingredient Iron Ii Sulfate B03Aa07 As Part Of A So Called Open House Model

Deadline: 28 Feb 2026

Germany

Ref. No.: 4656274

EMD:Ref Document

Bid Value: Ref Document

122 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Drugs With The Active Ingredient Eptinezumab N02Cd05 As Part Of A So Called Open House Model

Deadline: 28 Feb 2026

Germany

Ref. No.: 4646012

EMD:Ref Document

Bid Value: Ref Document

122 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Drugs With The Active Ingredient Pancreatin Lipase Containing Multienzymes A09Aa02 As Part Of A So Called Open House Model

Deadline: 28 Feb 2026

Germany

Ref. No.: 4644671

EMD:Ref Document

Bid Value: Ref Document

122 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicines With The Active Ingredients Vilanterol And Fluticasone Furoate R03Ak10 As Part Of A So Called Open House Model

Deadline: 28 Feb 2026

Germany

Ref. No.: 4643536

EMD:Ref Document

Bid Value: Ref Document

122 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicines With The Active Ingredient Fentanyl Only Sublingual Tablets Nasal Dosage Spray Or Lozenges N02Ab03 As Part Of A So C

Deadline: 28 Feb 2026

Germany

Ref. No.: 4643255

EMD:Ref Document

Bid Value: Ref Document

122 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Drugs With The Active Ingredients Fluticasone And Azelastine R01Ad28 As Part Of A So Called Open House Model

Deadline: 28 Feb 2026

Germany

Ref. No.: 4642060

EMD:Ref Document

Bid Value: Ref Document

122 Days Left

Medicines With The Active Ingredient Combination Oxycodone And Naloxone Atc N02Aa55

Deadline: 28 Feb 2026

Germany

Ref. No.: 4641976

EMD:Ref Document

Bid Value: Ref Document

122 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicines With The Active Ingredient Tolvaptan C03Xa01 As Part Of A So Called Open House Model

Deadline: 28 Feb 2026

Germany

Ref. No.: 4641684

EMD:Ref Document

Bid Value: Ref Document

122 Days Left

Medicines With The Active Ingredient Aclidinium Bromide Atc R03Bb05

Deadline: 28 Feb 2026

Germany

Ref. No.: 4641405

EMD:Ref Document

Bid Value: Ref Document

122 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicines With The Active Ingredient Pimecrolimus D11Ah02 As Part Of A So Called Open House Model

Deadline: 28 Feb 2026

Germany

Ref. No.: 4640967

EMD:Ref Document

Bid Value: Ref Document

122 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicines With The Active Ingredient Tolvaptan G04Bx21 As Part Of A So Called Open House Model

Deadline: 28 Feb 2026

Germany

Ref. No.: 4640900

EMD:Ref Document

Bid Value: Ref Document

122 Days Left

Showing 74911 to 74925 of 75161 results

‹
1
2
...
4992
4993
4994
4995
4996
4997
4998
...
5010
5011
›

Discover Tenders by Motion Capture Advance Medical Procedures Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Motion Capture Advance Medical Procedures Sector

Filter Your Search

FREE Trial plan for all new users!